MedGeneius provides a HIPAA-compliant, B2B pharmacogenomics (PGx) platform for labs and healthcare organizations. This software transforms raw genetic data into evidence-based, customizable PGx reports using authoritative sources like the FDA and CPIC. The platform enables organizations to deliver precision medicine insights that improve medication efficacy and reduce adverse drug reactions.
Funding
Funding not disclosed
Founders
Product
Problem
Current pharmacogenetic (PGx) testing methods often lack customization, failing to provide insights specific to individual needs, such as pediatric-focused reports or analysis of particular medications. Existing solutions may also struggle with efficient data uploads from various genetic testing sources and may not offer regularly updated reports reflecting the latest drug-gene research.
Solution
MedGeneius offers a customizable PGx reporting platform designed to deliver personalized medication insights by analyzing uploaded genetic data. The platform allows patients, healthcare providers, and laboratories to upload genetic data in formats like CSV or VCF, generating tailored reports based on user-defined specifications. MedGeneius enhances medication efficacy and reduces adverse drug reactions by providing evidence-based reports that are regularly updated with the latest drug-gene research. The software can be used as a full-service application or to create white-labeled reports, ensuring HIPAA compliance and reducing development costs.
Target Audience
MedGeneius targets individual patients seeking personalized medication insights, healthcare providers aiming to improve patient outcomes, laboratories looking to offer customizable PGx reports, genetic counselors needing comprehensive reporting tools, and researchers incorporating PGx data into clinical trials.
Features
- Customizable report generation based on user-specified medications or conditions
- Support for data uploads in CSV and VCF formats from various genetic testing services like AncestryDNA and 23andMe
- Regularly updated reports incorporating the latest drug-gene interaction research
- Option for pediatric-focused PGx reports
- HIPAA-compliant software to ensure data privacy and security
- White-labeling options for laboratories to offer customized reports under their brand
- Curated PGx data based on evidence from PharmGKB, CPIC, DPWG, and FDA